University of Rostock
Rostock, Mecklenburg-Vorpommern, 18057, Germany
NCT Number: NCT01631799
Total knee replacement is very common in Germany. After surgery patients have severe pain in the knee; initiation of the physiotherapy, however, is important in the first three days after surgery. Continuous femoral blockade and continuous (lumbar) epidural analgesia are commonly used after surgery. Both methods are used in Germany. Both methods have advantages and disadvantages. We wanted to answer the question which method of analgesia - after total knee replacement - is better concerning complications and function (after 3 months) ?
Looking for future studies?
Notify Me18 year–80 year
All sexes
Interventional
Not applicable
Rostock, Mecklenburg-Vorpommern, 18057, Germany
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Femoral catheter was inserted at the beginning of surgery. After surgery ropivacaine was administered continuously for three days. In addition, patients received piritramide via patient-controlled analgesia. The amount of ropivacaine was measured.
The epidural catheter was inserted at the beiginning of surgery. After surgery ropivacaine was applied continuously for three days. In addition, patients received piritramide via patient controlled analgesia. The amount of ropivacaine was measured.
Time frame: 3 months after surgery
3 months after surgery the function of the total knee replacement is testd
Time frame: 28 days after surgery
Time frame: 28 days after surgery
University of Rostock
Other
Outcome of Patients After Total Knee Replacement: A Comparison of Femoral Nerve Block and Epidural Anesthesia. A Randomized, Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04445428
COVID, Morbidity
Bissau, Guinea-Bissau
View Trial DetailsNCT03885206
Co-morbidity, Medical Emergencies
Sarpsborg, Østfold fylke, Norway
View Trial DetailsNCT03460002
Children, Measles Vaccination
Bissau, Guinea-Bissau
View Trial DetailsNCT05506748
Albumins, Hemoglobins
Bharatpur, Bagmati, Nepal
View Trial Details